A vaccine for multiple sclerosis Apitope Technology Ltd is a biopharmaceutical business that specialises in developing remedies for allergy and autoimmune illnesses. Formed simply because a spin-out business in 2002, Apitope announced in 2007 a vaccine had been developed by it made to halt multiple sclerosis in its tracks ajanta pharma . Cherry Lewis talked to Professor David Wraith, founder and Chief Scientific Officer, about the vaccine and his battle to get financing for clinical trials.
A female with orange-coloured palms Test thoroughly your diagnostic skills inside our regular dermatology quiz. Case presentation A 62-year-old girl presents to her GP to go over her osteoarthritis treatment. The individual is otherwise well. The rest of her skin and her sclerae are normal in appearance. Her current longstanding medicines include paracetamol and meloxicam on her behalf arthritis.